6-K 1 a2643n.htm DIRECTOR/PDMR SHAREHOLDING a2643n
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
 
 
For the month of September 2023
 
Commission File Number 001-15170
 
 
GSK plc
(Translation of registrant's name into English)
 
 
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive office)
 
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
 
 
 
 
GSK plc (the 'Company')
Transaction notification
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
 
Sir Jonathan Symonds
b)
Position/status
 
Non-Executive Chair
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
 
GSK plc
b)
LEI
 
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN: GB00BN7SWP63
 
b)
Nature of the transaction
 
Purchase of 1,900 Ordinary Shares
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
£15.2600
1,900
 
 
 
 
 
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
 
 
e)
Date of the transaction
 
2023-09-20
f)
Place of the transaction
 
London Stock Exchange (XLON)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
 
Urs Rohner
b)
Position/status
 
Independent Non-Executive Director
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
 
GSK plc
b)
LEI
 
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN: GB00BN7SWP63
 
b)
Nature of the transaction
 
Purchase of 453 Ordinary Shares
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
£15.2880
453
 
 
 
 
 
d)
Aggregated information
 
N/A (single transaction)
Aggregated volume Price
 
 
e)
Date of the transaction
 
2023-09-20
f)
Place of the transaction
 
London Stock Exchange (XLON)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
 
Charles Bancroft
b)
Position/status
 
Senior Independent Non-Executive Director
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
 
GSK plc
b)
LEI
 
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W2044
 
b)
Nature of the transaction
Purchase of 1,691 ADSs
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$38.0255
1,691
 
 
 
 
 
d)
Aggregated information
 
N/A (single transaction)
Aggregated volume Price
 
 
e)
Date of the transaction
 
2023-09-20
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
 
Dr Hal Barron
b)
Position/status
 
Non-Executive Director
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
 
GSK plc
b)
LEI
 
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W2044
 
b)
Nature of the transaction
 
Purchase of 219 ADSs
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$38.0255
219
 
 
 
 
 
d)
Aggregated information
 
N/A (single transaction)
Aggregated volume Price
 
 
e)
Date of the transaction
 
2023-09-20
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
 
Dr Anne Beal
b)
Position/status
 
Independent Non-Executive Director
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
 
GSK plc
b)
LEI
 
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W2044
 
b)
Nature of the transaction
 
Purchase of 220 ADSs
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$38.0255
220
 
 
 
 
 
d)
Aggregated information
 
N/A (single transaction)
Aggregated volume Price
 
 
e)
Date of the transaction
 
2023-09-20
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
 
Dr Harry Dietz
b)
Position/status
 
Independent Non-Executive Director
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
 
GSK plc
b)
LEI
 
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W2044
 
b)
Nature of the transaction
 
Purchase of 220 ADSs
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$38.0255
220
 
 
 
 
 
d)
Aggregated information
 
N/A (single transaction)
Aggregated volume Price
 
 
e)
Date of the transaction
 
2023-09-20
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
 
Dr Jesse Goodman
b)
Position/status
 
Independent Non-Executive Director
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
 
GSK plc
b)
LEI
 
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W2044
 
b)
Nature of the transaction
 
Purchase of 220 ADSs
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$38.0255
220
 
 
 
 
 
d)
Aggregated information
 
N/A (single transaction)
Aggregated volume Price
 
 
e)
Date of the transaction
 
2023-09-20
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
 
Elizabeth McKee Anderson
b)
Position/status
 
Independent Non-Executive Director
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
 
GSK plc
b)
LEI
 
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W2044
 
b)
Nature of the transaction
Purchase of 219 ADSs
 
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$38.0255
219
 
 
 
 
 
d)
Aggregated information
 
N/A (single transaction)
Aggregated volume Price
 
 
e)
Date of the transaction
 
2023-09-20
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
 
Dr Vishal Sikka
b)
Position/status
 
Independent Non-Executive Director
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
 
GSK plc
b)
LEI
 
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W2044
 
b)
Nature of the transaction
 
Purchase of 790 ADSs
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$38.0255
790
 
 
 
 
 
d)
Aggregated information
 
N/A (single transaction)
Aggregated volume Price
 
 
e)
Date of the transaction
 
2023-09-20
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
 
 
 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
GSK plc
 
(Registrant)
 
 
Date: September 21, 2023
 
 
 
 
By:/s/ VICTORIA WHYTE
--------------------------
 
 
 
Victoria Whyte
 
Authorised Signatory for and on
 
behalf of GSK plc